Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 2 Results

  1. 1

    Evidence for interventions included in the Minimum Package of Maternal and Newborn Interventions.

    Mridha MK

    MotherNewBorNews. 2006 Aug-Dec; 2(1):[15] p.

    In 2006, USAID and several of its partners agreed to the implementation of a minimum set of evidence-based interventions in maternal and newborn programs. These included a number of community-based and facility-based interventions that could be phased in to improve the survival and well being of mothers and newborns. These interventions have been tested in various operations research studies and have also been provided as an integrated package of services as described in subsequent sections of this newsletter. Below is a summary of evidence for each of the interventions. In the interest of brevity and simplicity, we have limited the evidence to just a few key studies. To keep the document consistent with the MAMAN framework described in the previous article, the evidence for MAMAN interventions has been described under three broad categories: I) Minimum maternal and newborn care, II) Other essential interventions, and III) Context specific interventions. (excerpt)
    Add to my documents.
  2. 2
    Peer Reviewed

    A single agenda needed for malaria.

    Lancet Infectious Diseases. 2003 Jun; 3(6):317.

    April 25 was Africa Malaria Day. It was masked by the release of the Africa Malaria Report, a joint publication by WHO and UNICEF and the first comprehensive report charting the progress made towards achieving the Abuja targets of reducing the malaria burden in Africa by 2010. The report praises the progress in fighting the disease but reveals that current coverage of effective interventions against malaria is unacceptably low. Mortality, morbidity, and the adverse economic impact of malaria increased during the 1990s. Only 15% of young children sleep under a net, and only 2% use nets that are treated by insecticide. Chloroquine has lost its clinical effectiveness in most parts of Africa Sulphadoxine-pyrimethamine is still useful but there are areas in western Kenya where resistance is fast rising. Furthermore, new effective antimalarial drugs are just not accessible to those who need them. The report urges the international community to step up the momentum, insisting that greater resources of money and political motivation are required to reverse the trend. (excerpt)
    Add to my documents.